Anavex (AVXL) Life Sciences announced the appointment of Professor Dr. Audrey Gabelle, MD, PhD, a specialist of predictive, personalized medicine and digital health in Alzheimer’ disease and related disorders, to the Anavex Scientific Advisory Board.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVXL:
- Largest borrow rate increases among liquid names
- Promising Potential of Anavex Life Sciences’ Blarcamesine in Alzheimer’s Treatment Reinforces Buy Rating
- Anavex announces results from Phase IIb/III open-label extension trial
- Buy Rating for Anavex: Capitalizing on European Market Opportunities Amid Eli Lilly’s Setback